Knockdown of the cell cycle inhibitor p21 enhances cartilage formation by induced pluripotent stem cells

Tissue Engineering - Part A

Volumn 21, Issue 7-8, 2015, Pages 1261-1274

  Diekman, Brian O ^a   Thakore, Pratiksha I ^b   O'Connor, Shannon K ^a,b   Willard, Vincent P ^a   Brunger, Jonathan M ^a,b   Christoforou, Nicolas ^b,c   Leong, Kam W ^b   Gersbach, Charles A ^a,b,d   Guilak, Farshid ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c KHALIFA UNIVERSITY   (United Arab Emirates)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; COLLAGEN; CYTOLOGY; EXPANSION; MONOLAYERS; PELLETIZING; STEM CELLS; TISSUE; TISSUE ENGINEERING;

ARTICULAR CARTILAGES; CARTILAGE FORMATION; CARTILAGE TISSUE ENGINEERING; CHONDROGENIC POTENTIAL; IMMUNOHISTOCHEMICAL ANALYSIS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE CAPACITY; SHORT HAIRPIN RNA (SHRNA);

CELL ENGINEERING;

CYCLIN DEPENDENT KINASE INHIBITOR 1; GLYCOSAMINOGLYCAN; SHORT HAIRPIN RNA; BROXURIDINE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL CYCLE; CELL DIFFERENTIATION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNTHESIS; TISSUE ENGINEERING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CHONDROGENESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELL; METABOLISM;

MURINAE;

ANIMALS; BROMODEOXYURIDINE; CARTILAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE X; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLYCOSAMINOGLYCANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MICE;

EID: 84927660038     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0240     Document Type: Article

References (69)

1. Mow, V.C., and Ratcliffe, A. Structure and function of articular cartilage. In: Mow, V.C., and Hayes, W.C., eds. Basic Orthopaedic Biomechanics. Philadelphia: Lippincott-Raven, 1997, pp. 113-177.
2. Loeser, R.F., Goldring, S.R., Scanzello, C.R., and Goldring, M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64, 1697, 2012.
3. Cicuttini, F., Ding, C., Wluka, A., Davis, S., Ebeling, P.R., and Jones, G. Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults: a prospective study. Arthritis Rheum 52, 2033, 2005.
4. Hjelle, K., Solheim, E., Strand, T., Muri, R., and Brittberg, M. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy 18, 730, 2002.
5. Hunziker, E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10, 432, 2002.
6. Johnstone, B., Alini, M., Cucchiarini, M., Dodge, G.R., Eglin, D., Guilak, F., et al. Tissue engineering for articular cartilage repair-the state of the art. Eur Cells Mater 25, 248, 2013.
7. Peterson, L., Brittberg, M., Kiviranta, I., Akerlund, E.L., and Lindahl, A. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30, 2, 2002.
8. Dickhut, A., Pelttari, K., Janicki, P., Wagner, W., Eckstein, V., Egermann, M., et al. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219, 219, 2009.
9. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B.G., et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54, 3254, 2006.
10. Hennig, T., Lorenz, H., Thiel, A., Goetzke, K., Dickhut, A., Geiger, F., et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211, 682, 2007.
11. Diekman, B.O., Rowland, C.R., Lennon, D.P., Caplan, A.I., and Guilak, F. Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix. Tissue Eng Part A 16, 523, 2010.
12. Cheng, A., Hardingham, T.E., and Kimber, S.J. Generating cartilage repair from pluripotent stem cells. Tissue Eng Part B Rev 20, 257, 2014.
13. Batty, L., Dance, S., Bajaj, S., and Cole, B.J. Autologous chondrocyte implantation: an overview of technique and outcomes. ANZ J Surg 81, 18, 2011.
14. Gosset, M., Berenbaum, F., Thirion, S., and Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 3, 1253, 2008.
15. Benya, P.D., Padilla, S.R., and Nimni, M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15, 1313, 1978.
16. von der Mark, K., Gauss, V., von der Mark, H., and Muller, P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267, 531, 1977.
17. Benya, P.D., and Shaffer, J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215, 1982.
18. Darling, E.M., and Athanasiou, K.A. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 23, 425, 2005.
19. Solchaga, L.A., Penick, K., Goldberg, V.M., Caplan, A.I., and Welter, J.F. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 16, 1009, 2010.
20. Estes, B.T., Wu, A.W., Storms, R.W., and Guilak, F. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adiposederived adult stem cells. J Cell Physiol 209, 987, 2006.
21. Diekman, B.O., Christoforou, N., Willard, V.P., Sun, H., Sanchez-Adams, J., Leong, K.W., et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci U S A 109, 19172, 2012.
22. Chang, B.D., Watanabe, K., Broude, E.V., Fang, J., Poole, J.C., Kalinichenko, T.V., et al. Effects of p21Waf1/Cip1/ Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 97, 4291, 2000.
23. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805, 1993.
24. Dombrowski, C., Helledie, T., Ling, L., Grunert, M., Canning, C.A., Jones, C.M., et al. FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors P21 and P27. Stem Cells 31, 2724, 2013.
25. Tsai, C.C., Chen, Y.J., Yew, T.L., Chen, L.L., Wang, J.Y., Chiu, C.H., et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST. Blood 117, 459, 2011.
26. Ito, T., Sawada, R., Fujiwara, Y., Seyama, Y., and Tsuchiya, T. FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 359, 108, 2007.
27. Bedelbaeva, K., Snyder, A., Gourevitch, D., Clark, L., Zhang, X.M., Leferovich, J., et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci U S A 107, 5845, 2010.
28. Kronenberg, H.M. Developmental regulation of the growth plate. Nature 423, 332, 2003.
29. Dexheimer, V., Frank, S., and Richter, W. Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. Stem Cells Dev 21, 2160, 2012.
30. Carey, B.W., Markoulaki, S., Hanna, J., Saha, K., Gao, Q., Mitalipova, M., et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106, 157, 2009.
31. Grant, T.D., Cho, J., Ariail, K.S., Weksler, N.B., Smith, R.W., and Horton, W.A. Col2-GFP reporter marks chondrocyte lineage and chondrogenesis during mouse skeletal development. Dev Dyn 218, 394, 2000.
32. Wiznerowicz, M., and Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77, 8957, 2003.
33. Pajalunga, D., Mazzola, A., Salzano, A.M., Biferi, M.G., De Luca, G., and Crescenzi, M. Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J Cell Biol 176, 807, 2007.
34. Salmon, P., and Trono, D. Production and titration of lentiviral vectors. In: Crawley, J.N., et al., eds. Current Protocols in Neuroscience. Hoboken, NJ: John Wiley & Sons, 2006, pp. 4-21.
35. Pozarowski, P., and Darzynkiewicz, Z. Analysis of cell cycle by flow cytometry. Methods Mol Biol 281, 301, 2004.
36. Estes, B.T., Diekman, B.O., Gimble, J.M., and Guilak, F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 5, 1294, 2010.
37. Detamore, M.S., and Athanasiou, K.A. Effects of growth factors on temporomandibular joint disc cells. Arch Oral Biol 49, 577, 2004.
38. Yew, T.L., Chiu, F.Y., Tsai, C.C., Chen, H.L., Lee, W.P., Chen, Y.J., et al. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells. Aging Cell 10, 349, 2011.
39. Bobick, B.E., Chen, F.H., Le, A.M., and Tuan, R.S. Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today 87, 351, 2009.
40. Kloxin, A.M., Kasko, A.M., Salinas, C.N., and Anseth, K.S. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59, 2009.
41. Shibata, K.R., Aoyama, T., Shima, Y., Fukiage, K., Otsuka, S., Furu, M., et al. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25, 2371, 2007.
42. Spencer, S.L., Cappell, S.D., Tsai, F.C., Overton, K.W., Wang, C.L., and Meyer, T. The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 155, 369, 2013.
43. Negishi, Y., Ui, N., Nakajima, M., Kawashima, K., Maruyama, K., Takizawa, T., et al. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem 276, 33249, 2001.
44. Owen, H.C., Ahmed, S.F., and Farquharson, C. Chondrocyte p21(WAF1/CIP1) expression is increased by dexamethasone but does not contribute to dexamethasone-induced growth retardation in vivo. Calcif Tissue Int 85, 326, 2009.
45. Simsa-Maziel, S., and Monsonego-Ornan, E. Interleukin-1beta promotes proliferation and inhibits differentiation of chondrocytes through a mechanism involving downregulation of FGFR-3 and p21. Endocrinology 153, 2296, 2012.
46. Su, W.C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., et al. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288, 1997.
47. Jakob, M., Demarteau, O., Schafer, D., Hintermann, B., Dick, W., Heberer, M., et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81, 368, 2001.
48. Barbero, A., Ploegert, S., Heberer, M., and Martin, I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 48, 1315 2003.
49. Martin, I., Vunjak-Novakovic, G., Yang, J., Langer, R., and Freed, L.E. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 253, 681, 1999.
50. Bradham, D.M., and Horton, W.E., Jr. In vivo cartilage formation from growth factor modulated articular chondrocytes. Clin Orthop Relat Res 239, 1998.
51. Guilak, F., Cohen, D.M., Estes, B.T., Gimble, J.M., Liedtke, W., and Chen, C.S. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5, 17, 2009.
52. Chen, K.G., Mallon, B.S., McKay, R.D., and Robey, P.G. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell 14, 13, 2014.
53. Vangsness, C.T., Jr., Farr, J., II, Boyd, J., Dellaero, D.T., Mills, C.R., and Leroux-Williams, M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am 96, 90, 2014.
54. Gourraud, P.A., Gilson, L., Girard, M., and Peschanski, M. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines. Stem Cells 30, 180, 2012.
55. Jones, D.G., and Peterson, L. Autologous chondrocyte implantation. J Bone Joint Surg Am 88, 2502, 2006.
56. Moutos, F.T., Freed, L.E., and Guilak, F. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater 6, 162, 2007.
57. Brunger, J.M., Huynh, N.P., Guenther, C.M., Perez-Pinera, P., Moutos, F.T., Sanchez-Adams, J., et al. Scaffoldmediated lentiviral transduction for functional tissue engineering of cartilage. Proc Natl Acad Sci U S A 111, E798, 2014.
58. Kim, M.J., Son, M.J., Son, M.Y., Seol, B., Kim, J., Park, J., et al. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum 63, 3010, 2011.
59. Wei, Y., Zeng, W., Wan, R., Wang, J., Zhou, Q., Qiu, S., et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cells Mater 23, 1, 2012.
60. Yamashita, A., Liu, S., Woltjen, K., Thomas, B., Meng, G., Hotta, A., et al. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Sci Rep 3, 1978, 2013.
61. Borestrom, C., Simonsson, S., Enochson, L., Bigdeli, N., Brantsing, C., Ellerstrom, C., et al. Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinicalgrade cell source. Stem Cells Transl Med 3, 433, 2014.
62. Xin, X., Jiang, X., Wang, L., Stover, M.L., Zhan, S., Huang, J., et al. A site-specific integrated Col2.3GFP reporter identifies osteoblasts within mineralized tissue formed in vivo by human embryonic stem cells. Stem Cells Transl Med 3, 1125, 2014.
63. Blin, G., Nury, D., Stefanovic, S., Neri, T., Guillevic, O., Brinon, B., et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120, 1125, 2010.
64. Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep 2, 205, 2014.
65. Martin-Caballero, J., Flores, J.M., Garcia-Palencia, P., and Serrano, M. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 61, 6234, 2001.
66. Rodriguez, R., Rubio, R., Masip, M., Catalina, P., Nieto, A., de la Cueva, T., et al. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia 11, 397, 2009.
67. Abbas, T., and Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9, 400, 2009.
68. Harvey, M., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., Bradley, A., and Donehower, L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 5, 225, 1993.
69. Sharpless, N.E., Bardeesy, N., Lee, K.H., Carrasco, D., Castrillon, D.H., Aguirre, A.J., et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86, 2001.